| abstract |
The present invention relates to diphenyloxyalkylamine derivatives and aryloxyalkylamine derivatives that are structurally analogous to mexiletine, said derivatives with significant biological activity and without causing unwanted side effects observed with the prototype, as well as with other drugs of the same therapeutic class as the prototype; the derivatives of the present invention have formulas II and III and are used to treat, prevent or inhibit inflammatory lung diseases, for example, asthma and chronic obstructive pulmonary disease (COPD). |